全文获取类型
收费全文 | 116289篇 |
免费 | 9276篇 |
国内免费 | 1143篇 |
专业分类
耳鼻咽喉 | 978篇 |
儿科学 | 1441篇 |
妇产科学 | 396篇 |
基础医学 | 5253篇 |
口腔科学 | 571篇 |
临床医学 | 3335篇 |
内科学 | 3739篇 |
皮肤病学 | 625篇 |
神经病学 | 3882篇 |
特种医学 | 1196篇 |
外国民族医学 | 2篇 |
外科学 | 3274篇 |
综合类 | 4900篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 1142篇 |
眼科学 | 92048篇 |
药学 | 2296篇 |
43篇 | |
中国医学 | 505篇 |
肿瘤学 | 1070篇 |
出版年
2023年 | 1842篇 |
2022年 | 3411篇 |
2021年 | 4046篇 |
2020年 | 3488篇 |
2019年 | 2916篇 |
2018年 | 3587篇 |
2017年 | 2775篇 |
2016年 | 3149篇 |
2015年 | 3632篇 |
2014年 | 6146篇 |
2013年 | 5859篇 |
2012年 | 6633篇 |
2011年 | 6952篇 |
2010年 | 5335篇 |
2009年 | 4770篇 |
2008年 | 5427篇 |
2007年 | 5607篇 |
2006年 | 5027篇 |
2005年 | 4647篇 |
2004年 | 4336篇 |
2003年 | 4157篇 |
2002年 | 3785篇 |
2001年 | 3788篇 |
2000年 | 3364篇 |
1999年 | 3039篇 |
1998年 | 958篇 |
1997年 | 735篇 |
1996年 | 566篇 |
1995年 | 590篇 |
1994年 | 539篇 |
1993年 | 555篇 |
1992年 | 2036篇 |
1991年 | 1886篇 |
1990年 | 1739篇 |
1989年 | 1533篇 |
1988年 | 1430篇 |
1987年 | 764篇 |
1986年 | 233篇 |
1985年 | 392篇 |
1984年 | 490篇 |
1983年 | 490篇 |
1982年 | 459篇 |
1981年 | 452篇 |
1980年 | 465篇 |
1979年 | 411篇 |
1978年 | 362篇 |
1977年 | 244篇 |
1976年 | 276篇 |
1974年 | 235篇 |
1973年 | 258篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Survey of ophthalmology》2023,68(5):920-928
There remains limited agreement regarding the efficacy and safety of different antivascular endothelial growth factor (anti-VEGF) agents for the management of polypoidal choroidal vasculopathy (PCV). Our meta-analysis compares different anti-VEGF agents for PCV treatment. Ovid MEDLINE, EMBASE, and Cochrane Library were systematically searched from January 2000 to July 2022. We included articles comparing the efficacy and safety of different anti-VEGF agents, specifically bevacizumab (BEV), ranibizumab (RAN), aflibercept AFL), and brolucizumab (BRO), for patients with PCV. 10,440 studies were identified, 122 underwent full-text review, and seven were included. One study was a randomized trial, and six were observational studies. Ranibizumab and aflibercept were associated with a similar best-corrected visual acuity (BCVA) at the last visit in three observational studies (P = 0.10), similar retinal thickness at the last visit in two observational studies (P = 0.85). One observational study comparing BEV versus RAN found comparable outcomes for final BCVA, retinal thickness, and polyp regression. One randomized trial on BRO versus AFL found comparable outcomes for improvement in BCVA, while anatomical outcomes favored BRO. The available evidence suggests that final BCVA is comparable across different anti-VEGF agents, however, further investigation is warranted due to paucity of evidence. 相似文献
3.
4.
5.
6.
7.
Diabetic retinopathy (DR) is one of the most important complications of diabetes. Accurate segmentation of DR lesions is of great importance for the early diagnosis of DR. However, simultaneous segmentation of multi-type DR lesions is technically challenging because of 1) the lack of pixel-level annotations and 2) the large diversity between different types of DR lesions. In this study, first, we propose a novel Poisson-blending data augmentation (PBDA) algorithm to generate synthetic images, which can be easily utilized to expand the existing training data for lesion segmentation. We perform extensive experiments to recognize the important attributes in the PBDA algorithm. We show that position constraints are of great importance and that the synthesis density of one type of lesion has a joint influence on the segmentation of other types of lesions. Second, we propose a convolutional neural network architecture, named DSR-U-Net++ (i.e., DC-SC residual U-Net++), for the simultaneous segmentation of multi-type DR lesions. Ablation studies showed that the mean area under precision recall curve (AUPR) for all four types of lesions increased by >5% with PBDA. The proposed DSR-U-Net++ with PBDA outperformed the state-of-the-art methods by 1.7%-9.9% on the Indian Diabetic Retinopathy Image Dataset (IDRiD) and 67.3% on the e-ophtha dataset with respect to mean AUPR. The developed method would be an efficient tool to generate large-scale task-specific training data for other medical anomaly segmentation tasks. 相似文献
8.
9.
10.
《Journal of AAPOS》2022,26(5):242.e1-242.e6
BackgroundPeripapillary hyperreflective ovoid masslike structures (PHOMS) are now considered a common cause of pseudopapilledema in the pediatric population.MethodsThe medical records of all patients ≤18 years of age with PHOMS, confirmed on optical coherence tomography, seen at single pediatric neuro-ophthalmology clinic between 2017 and 2021 were reviewed retrospectively.ResultsA total of 47 patients (35 females), with median age of 12.7 years at initial visit, were included. Of these, 24 (51%) of patients were optometry referrals. Headache was a common symptom. PHOMS were present bilaterally in all patients and were 360° around the disk in 57 of 94 eyes (61%). Patients with elevated intracranial pressure were more likely to have a reduction in the size of PHOMS at follow-up (P = 0.0133). Of the 47, 40 (85%) had diagnostic neuroimaging as a part of their papilledema workup. The retinal nerve fiber layer was thicker in patients with concomitant papilledema rather than optic disk drusen (P = 0.002) and compared with patients with PHOMS alone (P = 0.00051).ConclusionsPediatric patients with PHOMS may be referred because their clinical appearance can be suggestive of papilledema. In our study cohort, PHOMS were bilateral and frequently occurred concurrently with other ophthalmic conditions. 相似文献